Top Dow Jones Biotechnology Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
54.32 B
(0.06)
 2.05 
(0.12)
2AMGN Amgen Inc
28.19 B
(0.09)
 1.59 
(0.14)
3GILD Gilead Sciences
27.12 B
 0.19 
 1.43 
 0.27 
4REGN Regeneron Pharmaceuticals
13.12 B
(0.44)
 1.70 
(0.74)
5VRTX Vertex Pharmaceuticals
9.87 B
(0.05)
 1.73 
(0.08)
6BIIB Biogen Inc
9.84 B
(0.30)
 1.30 
(0.39)
7ILMN Illumina
4.5 B
 0.06 
 2.28 
 0.13 
8CRL Charles River Laboratories
4.13 B
(0.01)
 2.59 
(0.03)
9INCY Incyte
3.7 B
 0.07 
 2.47 
 0.17 
10RDUS Schnitzer Steel Industries
2.88 B
 0.13 
 4.15 
 0.52 
11BMRN Biomarin Pharmaceutical
2.42 B
(0.19)
 2.57 
(0.50)
12UTHR United Therapeutics
2.33 B
 0.07 
 1.73 
 0.12 
13NBIX Neurocrine Biosciences
1.89 B
(0.09)
 2.93 
(0.26)
14ALNY Alnylam Pharmaceuticals
1.83 B
(0.07)
 2.42 
(0.18)
15ALKS Alkermes Plc
1.66 B
 0.03 
 2.34 
 0.06 
16TECH Bio Techne Corp
1.16 B
 0.01 
 2.36 
 0.03 
17NVAX Novavax
983.71 M
(0.05)
 5.46 
(0.28)
18OPK Opko Health
863.5 M
(0.02)
 2.46 
(0.04)
19HALO Halozyme Therapeutics
829.25 M
(0.09)
 3.80 
(0.32)
20IONS Ionis Pharmaceuticals
787.65 M
(0.20)
 2.63 
(0.51)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.